Clinical Trials Directory

Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma

Conditions: Melanoma

Melanoma Institute Australia Wollstonecraft New South W...

Pulmonary Artery Remodelling With Bosentan

Conditions: Hypertension, Pulmonary

Royal Prince Alfred Hospital Camperdown

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous...

Conditions: Venous Thromboembolism

The University of Sydney Darlington New South Wales

Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants

Conditions: Healthy Participants

New Zealand Clinical Research Christchurch

To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Hea...

Conditions: Healthy Volunteers

Auckland Clinical Studies Auckland

Hartmann Versus Resection and Primary Anastomosis

Conditions: Colorectal Emergency

Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Ad...

Conditions: Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V, KRAS G12S, KRAS G12A, KR...

Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Di...

Conditions: Diabetic Macular Edema

Peking Union Medical College Hospital, Chinese Academy...

Frailty is a Risk Factor Postcholecystectomy

Conditions: Frailty, Gallbladder Diseases

[Trial of device that is not approved or cleared by the U.S. FDA]

Alveolar Ridge Splitting With Simvastatin/PRF Composite and Simultaneous Implant Placement

Conditions: Alveolar Ridge Atrophy, Tooth Loss

Faculty of Oral and Dental Surgery, Misr University for...

Effects of the DASH Diet and Lifestyle Modification on Blood Pressure in Adults With Prehyperte...

Conditions: Prehypertension, Prehypertension (Elevated Blood Pressure) or Hypertension

BAriaTric Surgery After Breast Cancer Treatment (BATS)

Conditions: Early-stage Breast Cancer, Obesity

[Trial of device that is not approved or cleared by the U.S. FDA]

Expanded Access to 0.5 mg eRapa for Familial Adenomatous Polyposis

Conditions: Familial Adenomatous Polyposis (FAP)

[Trial of device that is not approved or cleared by the U.S. FDA]

[Trial of device that is not approved or cleared by the U.S. FDA]

[Trial of device that is not approved or cleared by the U.S. FDA]

Quantitative In Vivo Monitoring of Early Erosion-Associated Enamel Optical Changes Using Swept-...

Conditions: Dental Erosion, Erosive Tooth Wear

[Trial of device that is not approved or cleared by the U.S. FDA]

Effect of Therapeutic Ultrasound Combined With Exercise on Subacromial Impingement Syndrome

Conditions: Shoulder Impingement Syndromes

[Trial of device that is not approved or cleared by the U.S. FDA]

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody...

Conditions: Solid Tumors

National Cancer Center Hospital East Chiba, Kashiwa

[Trial of device that is not approved or cleared by the U.S. FDA]